Observational Study on Skeletal Ewing's Sarcoma
Key facts
- Where
- Aviano, Bari, Bologna, Candiolo, Florence, Genova, Milan, Naples, Padova, Palermo, Parma, Pisa, Roma, Rome, Rozzano, Torino, and Trieste, ItalySee the 18 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 49 years old?
Source: NCT04845893, who can take part
Where in Italy
- Centro di Riferimento Oncologico - Unit of Medical OncologyAviano, ItalyTaking people
- Azienda Ospedaliero Universitaria Consorziale Policlinico - BariBari, ItalyTaking people
- A.O. Universitaria Policlinico S. Orsola Malpighi di BolognaBologna, ItalyTaking people
- Istituto Ortopedico RizzoliBologna, ItalyTaking people
- I.R.C.C. - Unit of Medical OncologyCandiolo, ItalyTaking people
- A.O. Universitaria MeyerFlorence, ItalyTaking people
- Istituto Giannina GasliniGenova, ItalyTaking people
- Fondazione IRCCS - Istituto Nazionale dei TumoriMilan, ItalyTaking people
- Azienda Ospedaliera Santobono PausiliponNaples, ItalyNot yet recruiting
- Azienda Ospedaliera di PadovaPadova, ItalyTaking people
- ARNAS P. O. "Civico e Benfratelli"Palermo, ItalyTaking people
- Azienda Ospedaliera - Universitaria di ParmaParma, ItalyTaking people
- Azienda Ospedaliero Universitaria PisanaPisa, ItalyTaking people
- Ospedale Pediatrico Bambin Gesu'Roma, ItalyNot yet recruiting
- Istituto Regina Elena - IFORome, ItalyTaking people
- Istituto Clinico HumanitasRozzano, ItalyTaking people
- Ospedale Infantile Regina Margherita - Unit of Paediatric OncoematologyTorino, ItalyTaking people
- IRCCS materno infantile Burlo GarofoloTrieste, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Italian Sarcoma Group
- Trial code
- NCT04845893
- Record updated
- 2 January 2026
- Original description
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by skeletal Ewing SarcomaRead full original descriptionShow less
Observational Study on Treatment of Skeletal Ewing Sarcoma at Diagnosis
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by skeletal Ewing Sarcoma
Inclusion: Diagnosis of Ewing's sarcoma of the bone; Diagnosis of Ewing-like sarcoma (round cell sarcoma with fusion of the EWSR1 gene with others not of the ETS family, sarcoma with CIC rearrangement or sarcoma with BCOR rearrangement); Diagnosis of extraosseous Ewing's sarcoma for patients; Age at diagnosis <50 years; Assessment of the extent of the disease at onset in accordance with the European Society of Medical Oncology guidelines; Patients or parents oe guardians of minors who have given their written informed consent to participate in the study.
Exclusion: Presence of comorbid factors who can compromise the compliance of the treatment plan or the evaluation of the outcomes, including but not limited to organ pathologies that contraindicate the use of chemotherapy and psychological or social conditions that do not allow for adequate compliance treatment or adequate follow-up.